
+39 02 36523300
-
Request information
-
Lun-Ven 10.00-18.30 GMT+01
It is used for treating exudative maculopathy. A substance that makes the patient sensitive to light is injected intravenously: this accumulates selectively in the neovessels (verteporfin) and after that, a non thermal laser is applied.
It is abolutely necessary not to be exposed to light for the next 3 days after treatment. This laser is especially ideal to treat maculopathy of patients with myopia and/or in association with antiangiogenetic therapy (anti-VEGF drugs).